ClinicalTrials.gov record
Not listed Phase 1 Interventional

Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants

ClinicalTrials.gov ID: NCT02731092

Public ClinicalTrials.gov record NCT02731092. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 12:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02731092
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 1
Lead sponsor
University of Virginia
Other
Enrollment
30 participants

Conditions and interventions

Interventions

  • Lactoferrin Dietary Supplement

Dietary Supplement

Eligibility (public fields only)

Age range
Up to 14 Days
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2016
Primary completion
Nov 30, 2016
Completion
Feb 28, 2017
Last update posted
Apr 18, 2016

2016 – 2017

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
University of Virginia Neonatal Intensive Care Unit Charlottesville Virginia 22908 Recruiting
University of Virginia HealthSystem Charlottesville Virginia 22932 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02731092, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2016 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02731092 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →